期刊文献+

DC-CIK细胞联合双径路化疗治疗非小细胞肺癌的临床疗效观察 被引量:1

下载PDF
导出
摘要 目的评价DC-CIK细胞联合双径路化疗治疗非小细胞肺癌的近期疗效及不良反应。方法选取62例非小细胞肺癌患者,随机纳入治疗组(31例)及对照组(31例)。治疗组采用DC-CIK细胞联合GP方案双径路化疗(生物治疗联合双径路化疗组),对照组采用单纯GP方案双径路化疗。治疗两周期后比较两组患者瘤体大小情况及不良反应。结果治疗组瘤体变化总有效率和稳定率分别为41.94%和80.65%,均较对照组瘤体变化总有效率和稳定率29.03%、61.29%高,差异具有统计学意义(P<0.05)。治疗组的不良反应与对照组比较差异无统计学意义(P>0.05)。结论与单纯双径路化疗相比,DC-CIK细胞联合双径路化疗治疗非小细胞肺癌疗效好,不增加不良反应。
作者 刘丹 王嵬
出处 《中国医药指南》 2015年第21期127-127,共1页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献31

  • 1You-ShunZhang Fang-JunYuan Guo-FengJia Ji-FaZhang Li-YiHu LingHuang Zong-QingDai.CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R[J].World Journal of Gastroenterology,2005,11(22):3339-3345. 被引量:24
  • 2王军业,戴淑琴,李宝江,林鹏,戎铁华,杨名添,龙浩,姚广裕,陈捷鑫.乳腺癌患者外周血T淋巴细胞AgNOR活性表达及其临床意义[J].中国肿瘤临床,2005,32(20):1158-1161. 被引量:4
  • 3王子平,孙燕,张湘茹,张茂宏,王秀问,于学军,南克俊,李恩孝,刘基巍,高亚杰,关小倩,宋恕平,盛立军,王东林,王志新.多西他赛治疗晚期乳腺癌的临床研究[J].中华肿瘤杂志,2006,28(6):468-470. 被引量:70
  • 4Wasil T,Lichtman SM. Clinical pharmacology issues relevant to the dosing and toxicioty of chemotherapy drvgs in the elderly[J]. Oncologist, 2005,10( 8 ) : 6021.
  • 5Nagaraj S, Ziske C, Schmidt-Wolf IG. Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer [ J]. Genet Vaccines Ther, 2004, 2 (1): 12.
  • 6Yamaguchi Y, Ohshita A, Kawabuchi Y. Adoptive immunotherapy of cancer using activated autologous lymphocytes - current status and new strategies [J]. Hum Cell, 2003, 16(4) : 183-189.
  • 7Marten A, Ziske C, Schottker B, et al. Interactions between dentritic cells and cytokine-induced killer cells lead to an activation of both populations [J]. J Immunol, 2001,24(6) : 502-510.
  • 8Wu C, Jiang J, Shi L, et al. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer [ J ]. Anticancer Res, 2008, 28(6B) : 39974002.
  • 9Chen HW, Liao CH, Ying C, et al. Ex vivo expansion of dendrit- ic-cell-activated antigen-specific CD4 + T cells with anti-CD3/ CD28, interleukin-7, and interleukin-15 : Potential for adoptive T cell immunotherapy [ J]. Clin Immunol, 2006, 119(1 ): 21-31.
  • 10Marten A, Renoth S, yon Lilienfeld-Total M, et al. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dentritic cells [ J]. Haematologica, 2001, 86(10): 1029-1037.

共引文献92

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部